Non-Surgical Peyronie's Disease Treatment in Knoxville, TN

It is used during the active, inflammatory phase — the earlier stage when there is discomfort and the condition is still changing. Low-dose radiation therapy is aimed at calming that inflammation. It is not a way to reverse a change in shape that has already settled and matured; that is a structural issue better discussed with a urologist. Individual results vary.

There are several non-surgical approaches, and which ones are reasonable depends on how far along the condition is. Low-dose radiation therapy is one option during the active, uncomfortable phase. Once things have stabilized, both non-surgical and surgical options are best reviewed with a urologist. No single approach suits everyone, and every other option stays open.

In the active, inflammatory phase the tissue is still irritated — there is often discomfort and the shape may still be changing from week to week, sometimes over many months. In the stable phase the inflammation has settled, discomfort usually fades, and the shape stops changing. Treatments that work by calming inflammation are relevant during the active phase, which is why knowing where you are matters more than the label.

That depends on whether the condition is still active. If you still have discomfort, or the shape seems to be changing, the inflammatory phase may still be open. If the discomfort passed a long time ago and nothing has changed since, that window has likely closed, and a urologist is the right person to discuss what remains available. It is worth asking rather than assuming.

The dose is a small fraction of the dose used to treat cancer and is directed at a limited area. Low-dose radiation therapy has been used for benign, non-cancerous conditions for decades. Side effects are uncommon and are usually mild and temporary, such as short-lived skin irritation. Any decision should be made with a clinician who has reviewed your situation.

No. You can call us directly. If you have an orthopedic surgeon, primary care physician, or rheumatologist, we coordinate with them.

No. You feel nothing during treatment. No needle, no injection, no anesthesia.

Rare. Some patients notice mild, temporary skin redness. No systemic side effects.

The dose used for benign conditions is 10 to 25 times lower than the dose used to treat cancer. Long-term studies in Germany — where LDRT has been used for decades — have not shown an increased cancer risk at these low doses. We do not treat patients under 40 except in specific circumstances.

Most patients begin noticing relief between 6 and 12 weeks after their final session. About 70% report meaningful improvement.

Typically 12 to 24 months. A second course can be given if symptoms return.

Most patients respond well — and if your consultation shows you're not a strong candidate, we'll tell you up front, before you've spent a dime. LDRT also never closes any doors: every other option, including surgery, stays open to you.

Most major insurance is accepted, including Medicare and major commercial plans. Our office handles all insurance pre-authorization.

Most benign musculoskeletal conditions require 6 to 8 weekday sessions, scheduled on consecutive business days so you complete a full course in under two weeks. Each session takes about 15 minutes. Some skin and fibrotic conditions follow different protocols — your consultation will clarify what fits your situation.